Single dose of fluoxetine increases muscle activation in chronic stroke patients

Clinical Neuropharmacology

Volumn 32, Issue 1, 2009, Pages 1-5

  Berends, Hanneke Irene ^a   Nijlant, Juliëtte M M ^a,b   Van Putten, Michel J A M ^c   Movig, Kris L L ^d   Ijzerman, Maarten J ^a,e  

^a ROESSINGH RESEARCH AND DEVELOPMENT   (Netherlands)

^b TWENTEBORG HOSPITAL   (Netherlands)

^c Clinical Neurophysiology   (Germany)

^d MEDISCH SPECTRUM TWENTE   (Netherlands)

^e UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

EMG; Fluoxetine; Motor function; Serotonin; Stroke recovery

Indexed keywords

FLUOXETINE; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADULT; ARM MUSCLE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTROMYOGRAM; FEMALE; GRIP STRENGTH; HUMAN; MALE; MOTOR DYSFUNCTION; MOTRICITY INDEX; MUSCLE FUNCTION; MUSCLE ISOMETRIC CONTRACTION; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SINGLE DRUG DOSE; STROKE;

ADULT; ARM; CHRONIC DISEASE; CROSS-OVER STUDIES; ELECTROMYOGRAPHY; FEMALE; FLUOXETINE; HAND STRENGTH; HUMANS; MALE; MUSCLE CONTRACTION; MUSCLE STRENGTH; PILOT PROJECTS; SEROTONIN UPTAKE INHIBITORS; STROKE;

EID: 67749147379     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181633482     Document Type: Article

References (30)

1. Chae J, Yang G, Park B, et al. Muscle weakness and cocontraction in upper limb hemiparesis: relationship to motor impairment and physical disability. Neurorehabil Neural Repair 2002;16:241-248.
2. Hammond M, Fitts S, Kraft G, et al. Co-contraction in the hemiparetic forearm: quantitative EMG evaluation. Arch Phys Med Rehabil 1988;69:348-351.
3. Chae J, Yang G, Park B, et al. Delay in initiation and termination of muscle contraction, motor impairment, and physical disability in upper limb hemiparesis. Muscle Nerve 2002;25:568-575.
4. Rossini P, Dal Forno G. Integrated technology for evaluation of brain function and neural plasticity. Phys Med Rehabil Clin N Am 2004;15: 263-306.
5. Chen R, Cohen L, Hallett M. Nervous system reorganization following injury. Neuroscience 2002;111:761-773.
6. Talelli P, Greenwood R, Rothwell J. Arm function after stroke: Neurophysiological correlates and recovery mechanisms assessed by transcranial magnetic stimulation. Clin Neurophysiol 2006;117: 1641-1659.
7. Boyeson M, Harmon R, Jones J. Comparative effects of fluoxetine, amitryptiline and serotonin on functional motor recovery after sensorimotor cortex injury. Am J Phys Med Rehabil 1994;73:76-83.
8. Crisostomo E, Duncan P, Propst M, et al. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol 1988;23:94-97.
9. Goldstein L. Potential effects of common drugs on stroke recovery. Arch Neurol 1998;55:454-456.
10. Pariente J, Loubinoux I, Carel C, et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 2001;50:718-729.
11. Sivenius J, Sarasoja T, Aaltonen H, et al. Selegiline treatment facilitates recovery after stroke. Neurorehabil Neurol Repair 2001;15:183-190.
12. Liepert J, Bauder H, Miltner W, et al. Treatment-induced cortical reorganization after stroke in humans. Stroke 2000;31:1210-1216.
13. Jacobs B, Fornal C. Activity of serotonergic neurons in behaving animals. Neuropsychopharmacology 1999;21:9S-15S.
14. Loubinoux I, Pariente J, Boulanouar K, et al. A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: double-blind, placebo-controlled, fMRI study in healthy subjects. Neuroimage 2002;15:26-36.
15. Loubinoux I, Boulanouar K, Ranjeva J, et al. Cerebral functional magnetic resonance imaging activation modulated by a single dose of the monamine neurotransmission enhancers fluoxetine and fenozolone during hand sensorimotor tasks. J Cereb Blood Flow Metab 1999;19: 1365-1375.
16. Loubinoux I, Tombari D, Pariente J, et al. Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer. Neuroimage 2005;27:299-313.
17. Gerdelat-Mas A, Loubinoux I, Tombari DRO, et al. Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects. Neuroimage 2005;27:314-322.
18. Dam M, Tonin P, De Boni A, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996;27:1211-1214.
19. Robinson R, Schultz S, Castillo C, et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry 2000;157:351-359.
20. Pleger B, Schwenkreis P, Grünberg C, et al. Fluoxetine facilitates use-dependent excitability of human primary motor cortex. Clin Neurophysiol 2004;115:2157-2163.
21. Keller T, Cambon N, Genevray M, et al. Bioequivalence study of fluoxetine hydrochloride in healthy volunteers. Arzneimittelforschung 2005;55:491-497.
22. Collin C, Wade D. Assessing motor impairment after stroke: a pilot reliability study. J Neurol Neurosurg Psychiatry 1990;53:576-579.
23. Sunderland A, Tinson D, Bradley L, et al. Arm function after stroke. An evaluation of grip strength as a measure of recovery and a prognostic indicator. J Neurol Neurosurg Psychiatry 1989;52:1267-1272.
24. Mathiowetz V, Weber K, Volland G, et al. Reliability and validity of grip and pinch strength evaluation. J Hand Surg 1984;9:222-226.
25. Perry K, Fuller R. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci 1992;50:1683-1690.
26. Rutter J, Gundlah C, Auerback S. Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci Lett 1994;171:183-186.
27. Guan X, McBride W. Fluoxetine increases the extracellular levels of serotonin in the nucleus accumbens. Brain Res Bull 1988;21:43-46.
28. Mück-Šeler D, Jevric-Causevic A, Diksic M. Influence of fluoxetine on regional serotonin synthesis in the rat brain. J Neurochem 1996;67: 2434-2442.
29. Hasbroucq T, Rihet P, Blin O, et al. Serotonin and human information processing: fluvoxamine can improve reaction time performance. Neurosci Let 1997;229:204-208.
30. Rihet P, Hasbroucq T, Blin O, et al. Serotonin and human information processing: an electromyographic study of the effects of fluvoxamine on choice reaction time. Neurosci Lett 1999;265:143-146.